Neoadjuvant chemotherapy with or without preoperative irradiation in stage IIIA/N2 non-small cell lung cancer (NSCLC): A randomized phase III trial by the Swiss Group for Clinical Cancer Research (SAKK trial 16/00).Miklos Pless, Sandra Thierstein, Alexandros Xyrafas et al.|Journal of Clinical Oncology|2013Cited by 19
SAKK 17/16 - Lurbinectedin as second or third line palliative chemotherapy in malignant pleural mesothelioma (MPM): A multi-center, single-arm phase II trialYannis Metaxas, Roger von Moos, M. Frueh et al.|Annals of Oncology|2019Cited by 2
143PD: Bevacizumab and pemetrexed versus pemetrexed alone as maintenance therapy for patients with advanced nonsquamous NSCLC: Results of the expanded SAKK19/09 trialOliver Gautschi, Adrian F. Ochsenbein, Q Li et al.|Journal of Thoracic Oncology|2016Cited by 0